Recombinant sP-sel treatment in mice is associated with induction of the procoagulant state30 and can correct hemostasis in a mouse model of hemophilia A through interaction with PSGL-1 to generate procoagulant tissue factor (TF)-positive microparticles (MPs) (TF+-MPs)31. Here, F3 is linked to hemophilia A.